Financhill
Back

Canopy Growth Quote, Financials, Valuation and Earnings

Canopy Growth Price Quote

$2.82
-0.01 (4.06%)
(Updated: December 21, 2024 at 5:19 AM ET)

Canopy Growth Key Stats

Sell
24
Canopy Growth (CGC) is a Sell

Day range:
$2.70 - $2.88
52-week range:
$2.70 - $14.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.16
P/B ratio:
0.92%

Volume:
8.8M
Avg. volume:
5.4M
1-year change:
-41.04%
Market cap:
$346.4M
Revenue:
$220.2M
EPS:
$-4.7

How Much Does Canopy Growth Make?

Data Unavailable

Is Canopy Growth Growing As A Company?

Data Unavailable

Canopy Growth Stock Price Performance

  • Did Canopy Growth Stock Go Up Last Month?
    Canopy Growth share price went down by -24.73% last month
  • Did CGC's Share Price Rise Over The Last Year?
    CGC share price fell by -41.04% over the past 1 year

What Is Canopy Growth 52-Week High & Low?

Canopy Growth Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Canopy Growth?

Data Unavailable

Is Canopy Growth Cash Flow Positive?

Data Unavailable

Canopy Growth Return On Invested Capital

Data Unavailable

Canopy Growth Earnings Date & Stock Price

  • What Is Canopy Growth's Stock Price Today?
    A single share of CGC can be purchased today for 2.83
  • What Is Canopy Growth’s Stock Symbol?
    Canopy Growth trades on the nasdaq under the ticker symbol: CGC
  • When Is Canopy Growth’s Next Earnings Date?
    The next quarterly earnings date for Canopy Growth is scheduled on February 7, 2025
  • When Is CGC's next ex-dividend date?
    Canopy Growth's next ex-dividend date is May 26, 2020
  • How To Buy Canopy Growth Stock?
    You can buy Canopy Growth shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Canopy Growth Competitors

  • Who Are Canopy Growth's Competitors?
    Below is a list of companies who compete with Canopy Growth or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • Lexaria Bioscience Corp (LEXX)
    • Tilray Brands Inc (TLRY)
    • Xenon Pharmaceuticals Inc (XENE)

Canopy Growth Dividend Yield

Data Unavailable

Canopy Growth Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -270.07%
Revenue: -10.99% -4.91%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 5
Sell Recommendations: 3
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable